Scientech Research »

Adagio Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2025-09-30 $16k 14k 1.10

More positions owned by Scientech Research

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Applovin Corp Com Cl A (APP)
Eli Lilly & Co. (LLY)
Regeneron Pharmaceuticals (REGN)
Alnylam Pharmaceuticals (ALNY)
Tilray (TLRY)
Uniqure Nv SHS (QURE)
Mongodb Cl A (MDB)
Insulet Corporation (PODD)
Transocean Registered Shs (RIG)
Zebra Technologies Corporati Cl A (ZBRA)
Robinhood Mkts Com Cl A (HOOD)
Graniteshares Etf Tr 2x Long Nvda Dai (NVDL)
Adobe Systems Incorporated (ADBE)

View all positions for Scientech Research

Top funds holding Adagio Therapeutics

Henderson Group
Point72 Asset Management
Maverick Capital
RA Capital Management
Mithril II GP
Driehaus Capital Management
M28 Capital Management
ADAR1 Capital Management
683 Capital Management
Vanguard Group
Redmile Group
Ikarian Capital
Eversept Partners
Millennium Management
Boothbay Fund Management

View all funds holding Adagio Therapeutics